FKBP8 Antibodies

Santa Cruz Biotechnology delivers a wide array of FKBP8 monoclonal antibodies for research focused on understanding FKBP8's role in various biological processes. FKBP8 monoclonal antibodies are validated for multiple applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FKBP8, or FK506-binding protein 8, is a member of the immunophilin family and plays a critical role in protein folding and trafficking, as well as in the regulation of apoptosis and cellular stress responses. FKBP8's involvement in various signaling pathways makes it an important target for studying diseases such as cancer and neurodegenerative disorders. Understanding FKBP8's function can provide insights into therapeutic strategies aimed at modulating its activity. FKBP8 monoclonal antibodies enable precise detection and analysis of FKBP8 expression patterns across different cell types and tissues. Researchers can investigate FKBP8's interactions with other proteins and its role in cellular pathways. FKBP8 monoclonal antibodies from Santa Cruz Biotechnology support scientists worldwide in advancing our understanding of cellular mechanisms and potential therapeutic applications.